Cargando…
Minimal ablative margin (MAM) assessment with image fusion: an independent predictor for local tumor progression in hepatocellular carcinoma after stereotactic radiofrequency ablation
OBJECTIVES: To assess the minimal ablative margin (MAM) by image fusion of intraprocedural pre- and post-ablation contrast-enhanced CT images and to evaluate if it can predict local tumor progression (LTP) independently. Furthermore, to determine a MAM with which a stereotactic radiofrequency ablati...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7160081/ https://www.ncbi.nlm.nih.gov/pubmed/32002642 http://dx.doi.org/10.1007/s00330-019-06609-7 |
_version_ | 1783522686568235008 |
---|---|
author | Laimer, Gregor Schullian, Peter Jaschke, Nikolai Putzer, Daniel Eberle, Gernot Alzaga, Amilcar Odisio, Bruno Bale, Reto |
author_facet | Laimer, Gregor Schullian, Peter Jaschke, Nikolai Putzer, Daniel Eberle, Gernot Alzaga, Amilcar Odisio, Bruno Bale, Reto |
author_sort | Laimer, Gregor |
collection | PubMed |
description | OBJECTIVES: To assess the minimal ablative margin (MAM) by image fusion of intraprocedural pre- and post-ablation contrast-enhanced CT images and to evaluate if it can predict local tumor progression (LTP) independently. Furthermore, to determine a MAM with which a stereotactic radiofrequency ablation (SRFA) can be determined successful and therefore used as an intraprocedural tool to evaluate treatment success. METHODS: A total of 110 patients (20 women, 90 men; mean age 63.7 ± 10.2) with 176 hepatocellular carcinomas were assessed by retrospective analysis of prospectively collected data. The MAM was determined through image fusion of intraprocedural pre- and post-ablation images using commercially available rigid imaging registration software. LTP was assessed in contrast-enhanced CTs or MR scans at 3–6-month intervals. RESULTS: The MAM was the only significant independent predictor of LTP (p = 0.036). For each millimeter increase of the MAM, a 30% reduction of the relative risk for LTP was found (OR = 0.7, 95% CI 0.5–0.98, p = 0.036). No LTP was detected in lesions with a MAM > 5 mm. The overall LTP rate was 9 of 110 (8.2%) on a patient level and 10 of 173 (5.7%) on a lesion level. The median MAM was 3.4 (1.7–6.9) mm. The mean overall follow-up period was 26.0 ± 10.3 months. CONCLUSIONS: An immediate assessment of the minimal ablative margin (MAM) can be used as an intraprocedural tool to evaluate the treatment success in patients treated with stereotactic RFA. A MAM > 5 mm has to be achieved to consider an ablation as successful. KEY POINTS: • An intraoperatively measured minimal ablative margin (MAM) > 5 mm correlates with complete remission. • MAM is the only significant independent predictor of LTP (OR = 0.7, 95% CI 0.5–0.98, p = 0.036) after stereotactic RFA of hepatocellular carcinoma. • Image fusion using commercially available rigid imaging registration software is possible, even though considerably complex. Therefore, improved (semi-)automatic fusion software is highly desirable. |
format | Online Article Text |
id | pubmed-7160081 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Springer Berlin Heidelberg |
record_format | MEDLINE/PubMed |
spelling | pubmed-71600812020-04-23 Minimal ablative margin (MAM) assessment with image fusion: an independent predictor for local tumor progression in hepatocellular carcinoma after stereotactic radiofrequency ablation Laimer, Gregor Schullian, Peter Jaschke, Nikolai Putzer, Daniel Eberle, Gernot Alzaga, Amilcar Odisio, Bruno Bale, Reto Eur Radiol Interventional OBJECTIVES: To assess the minimal ablative margin (MAM) by image fusion of intraprocedural pre- and post-ablation contrast-enhanced CT images and to evaluate if it can predict local tumor progression (LTP) independently. Furthermore, to determine a MAM with which a stereotactic radiofrequency ablation (SRFA) can be determined successful and therefore used as an intraprocedural tool to evaluate treatment success. METHODS: A total of 110 patients (20 women, 90 men; mean age 63.7 ± 10.2) with 176 hepatocellular carcinomas were assessed by retrospective analysis of prospectively collected data. The MAM was determined through image fusion of intraprocedural pre- and post-ablation images using commercially available rigid imaging registration software. LTP was assessed in contrast-enhanced CTs or MR scans at 3–6-month intervals. RESULTS: The MAM was the only significant independent predictor of LTP (p = 0.036). For each millimeter increase of the MAM, a 30% reduction of the relative risk for LTP was found (OR = 0.7, 95% CI 0.5–0.98, p = 0.036). No LTP was detected in lesions with a MAM > 5 mm. The overall LTP rate was 9 of 110 (8.2%) on a patient level and 10 of 173 (5.7%) on a lesion level. The median MAM was 3.4 (1.7–6.9) mm. The mean overall follow-up period was 26.0 ± 10.3 months. CONCLUSIONS: An immediate assessment of the minimal ablative margin (MAM) can be used as an intraprocedural tool to evaluate the treatment success in patients treated with stereotactic RFA. A MAM > 5 mm has to be achieved to consider an ablation as successful. KEY POINTS: • An intraoperatively measured minimal ablative margin (MAM) > 5 mm correlates with complete remission. • MAM is the only significant independent predictor of LTP (OR = 0.7, 95% CI 0.5–0.98, p = 0.036) after stereotactic RFA of hepatocellular carcinoma. • Image fusion using commercially available rigid imaging registration software is possible, even though considerably complex. Therefore, improved (semi-)automatic fusion software is highly desirable. Springer Berlin Heidelberg 2020-01-30 2020 /pmc/articles/PMC7160081/ /pubmed/32002642 http://dx.doi.org/10.1007/s00330-019-06609-7 Text en © The Author(s) 2019 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Interventional Laimer, Gregor Schullian, Peter Jaschke, Nikolai Putzer, Daniel Eberle, Gernot Alzaga, Amilcar Odisio, Bruno Bale, Reto Minimal ablative margin (MAM) assessment with image fusion: an independent predictor for local tumor progression in hepatocellular carcinoma after stereotactic radiofrequency ablation |
title | Minimal ablative margin (MAM) assessment with image fusion: an independent predictor for local tumor progression in hepatocellular carcinoma after stereotactic radiofrequency ablation |
title_full | Minimal ablative margin (MAM) assessment with image fusion: an independent predictor for local tumor progression in hepatocellular carcinoma after stereotactic radiofrequency ablation |
title_fullStr | Minimal ablative margin (MAM) assessment with image fusion: an independent predictor for local tumor progression in hepatocellular carcinoma after stereotactic radiofrequency ablation |
title_full_unstemmed | Minimal ablative margin (MAM) assessment with image fusion: an independent predictor for local tumor progression in hepatocellular carcinoma after stereotactic radiofrequency ablation |
title_short | Minimal ablative margin (MAM) assessment with image fusion: an independent predictor for local tumor progression in hepatocellular carcinoma after stereotactic radiofrequency ablation |
title_sort | minimal ablative margin (mam) assessment with image fusion: an independent predictor for local tumor progression in hepatocellular carcinoma after stereotactic radiofrequency ablation |
topic | Interventional |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7160081/ https://www.ncbi.nlm.nih.gov/pubmed/32002642 http://dx.doi.org/10.1007/s00330-019-06609-7 |
work_keys_str_mv | AT laimergregor minimalablativemarginmamassessmentwithimagefusionanindependentpredictorforlocaltumorprogressioninhepatocellularcarcinomaafterstereotacticradiofrequencyablation AT schullianpeter minimalablativemarginmamassessmentwithimagefusionanindependentpredictorforlocaltumorprogressioninhepatocellularcarcinomaafterstereotacticradiofrequencyablation AT jaschkenikolai minimalablativemarginmamassessmentwithimagefusionanindependentpredictorforlocaltumorprogressioninhepatocellularcarcinomaafterstereotacticradiofrequencyablation AT putzerdaniel minimalablativemarginmamassessmentwithimagefusionanindependentpredictorforlocaltumorprogressioninhepatocellularcarcinomaafterstereotacticradiofrequencyablation AT eberlegernot minimalablativemarginmamassessmentwithimagefusionanindependentpredictorforlocaltumorprogressioninhepatocellularcarcinomaafterstereotacticradiofrequencyablation AT alzagaamilcar minimalablativemarginmamassessmentwithimagefusionanindependentpredictorforlocaltumorprogressioninhepatocellularcarcinomaafterstereotacticradiofrequencyablation AT odisiobruno minimalablativemarginmamassessmentwithimagefusionanindependentpredictorforlocaltumorprogressioninhepatocellularcarcinomaafterstereotacticradiofrequencyablation AT balereto minimalablativemarginmamassessmentwithimagefusionanindependentpredictorforlocaltumorprogressioninhepatocellularcarcinomaafterstereotacticradiofrequencyablation |